Search
for

    Sort by

    Research 181–210 of 1000+

    1. History as a Tool in Identifying “New” Old Drugs Advances in experimental medicine and biology · 2002 · 26 citations
    2. 13C-NMR study of 4-azasteroids in solution and solid state Steroids · 2002 · 25 citations
    3. A regulatory perspective on pharmacokinetic/pharmacodynamic modelling Statistical Methods in Medical Research · 1999 · 18 citations
    4. Endocrine treatment of benign prostatichypertrophy: Current concepts Urology · 1991 · 11 citations
    5. Steady-state pharmacokinetics of oral testosterone undecanoate with concomitant inhibition of 5α-reductase by finasteride International Journal of Andrology · 2010 · 10 citations
    6. Effect of finasteride on serum concentrations of dihydrotestosterone and testosterone in three clinically normal sexually intact adult male dogs. PubMed · 1998 · 10 citations
    7. MAINTENANCE AND RESTORATION OF GROWTH IN THYROIDECTOMIZED RATS Journal of Endocrinology · 1942 · 8 citations
    8. Severity of Alopecia Predicts Coronary Changes and Arterial Stiffness in Untreated Hypertensive Men Journal of Clinical Hypertension · 2016 · 5 citations
    9. Finasteride use during pregnancy and early neonatal outcome: a case report International Journal of Clinical Pharmacy · 2018 · 3 citations
    10. 5α-Reductase Inhibitors – The Finasteride Story Wiley-VCH Verlag GmbH & Co. KGaA eBooks · 2010 · 3 citations
    11. The synthesis of (−)-4-methyl-8-chloro-trans-1,2,3,4,4a,5,6,10b-octahydrobenzo-[f]-quinolin-3-one-[3-14C] (LY300502-14C]) via a circuitous route Journal of Labelled Compounds and Radiopharmaceuticals · 1994 · 3 citations
    12. Anabolic-Androgenic Steroids and Cardiometabolic Derangements Cureus · 2021 · 2 citations
    13. Effects of hyperbaric oxygen therapy on rat facial skin Human & Experimental Toxicology · 2015 · 2 citations
    14. Antiandrogenic activity of Riboflavin 5′-phosphate (FMN) in 22Rv1 and LNCaP human prostate cancer cell lines European Journal of Pharmacology · 2022 · 1 citations
    15. 664 Understanding the pathogenesis of seborrhea-like dermatitis in the Mpzl3 knockout mice Journal of Investigative Dermatology · 2017 · 1 citations
    16. Using 5 alpha reductase inhibitors safely: What primary care physicians need to know Journal of Family Medicine and Primary Care · 2024
    17. Secondary Cutis Verticis Gyrata Induced by Long-Term Use of High-Dose Topical Minoxidil Skin Appendage Disorders · 2024
    18. Comment on “The post-finasteride syndrome: possible etiological mechanisms and symptoms” International journal of impotence research · 2024
    19. Polycystic Ovary Syndrome and Inflammation ISGE series · 2021
    20. Androgen-induced norepinephrine release in male accessory sex organ smooth muscle growth and differentiation 2019
    21. MP85-05 SEXUAL DYSFUNCTION AFTER 5-ALPHA REDUCTASE INHIBITOR USE: INSIGHTS FROM THE REDUCE STUDY GROUP DATABASE The Journal of Urology · 2018
    22. Screening of steroid 5-reductase inhibitory activity and total phenolic content of Thai plants Journal of Medicinal Plants Research · 2011
    23. 5α-Reductase inhibitor therapy: Should physicians be concerned with persistent diminished libido, erectile dysfunction and depression in a subset of patients? Journal of Men's Health · 2010
    24. Total prostate volume as risk factor for semen pathologies in ageing male Journal of Men's Health · 2010
    25. NEURONAL MIMICRY AS A RESISTANCE PHENOTYPE IN CANCER CELLS The Journal of Urology · 2009
    26. Finasteride en mammacarcinoom bij mannen Medisch-Farmaceutische Mededelingen · 2004
    27. TACRINE 2004
    28. Dutasteride/finasteride Reactions Weekly · 2021
    29. Dutasteride for Androgenetic Alopecia—Words of Caution Hair transplant forum international · 2002
    30. Current treatment of BPH Biomedicine & pharmacotherapy · 1995 · 11 citations